ResMed revenue and financials
$220.69Change from previous close: −0.97%Absolute change: −$2.17
In the fiscal year ended June 2026, ResMed reported revenue of $5.65B (+9.85% year over year). Net income was $1.52B, a net margin of 26.9%.
Fiscal year ending in June. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +9.85%
- FY to Jun 2026 vs FY to Jun 2025
- Net income growth
- +8.75%
- FY to Jun 2026 vs FY to Jun 2025
- Net margin
- 26.9%
- FY to Jun 2025: 27.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 455 | 554 | 340 | 457 | 539 | 579 | 309 | 326 | 440 | 402 | 273 | 286 |
| Depreciation and amortization | 48.8 | 62.6 | 55.9 | 51.3 | 67.9 | 45.6 | 49.5 | 47.3 | 48.0 | 47.9 | 46.4 | 46.5 |
| Capital expenditure | -51.1 | -33.7 | -28.5 | -43.0 | -30.6 | -20.8 | -20.6 | -17.8 | -24.9 | -21.2 | -23.4 | -30.0 |
| Investing cash flow | -384 | -58.0 | -50.9 | -52.6 | -134 | -31.8 | -36.7 | 2.1 | -46.5 | -33.2 | -41.1 | -149 |
| Financing cash flow | -263 | -255 | -258 | -230 | -164 | -144 | -148 | -151 | -393 | -336 | -239 | -151 |
| Dividends paid | -87.1 | -87.2 | -87.6 | -87.8 | -77.6 | -77.7 | -77.7 | -77.9 | -70.6 | -70.5 | -70.7 | -70.6 |
| Share repurchases | -200 | -175 | -195 | -151 | -101 | -75.4 | -91.7 | -50.4 | -50.4 | -50.3 | -57.8 | -0.2 |
| Debt issued | — | — | — | — | 0.0 | 0.0 | — | — | — | — | — | 105 |
| Debt repaid | -5.0 | 0.0 | -5.0 | 0.0 | -5.0 | — | -5.0 | -30.0 | -300 | -220 | -130 | -185 |
| Effect of exchange rates | 0.9 | 2.6 | 2.8 | -0.1 | 35.6 | 8.0 | -28.8 | 11.1 | 0.1 | -5.3 | 8.4 | -5.0 |
| Net change in cash | -191 | 243 | 33.2 | 174 | 277 | 411 | 95.6 | 188 | 0.5 | 27.7 | 1.1 | -18.8 |
| Free cash flow | 404 | 520 | 311 | 414 | 508 | 558 | 288 | 308 | 415 | 381 | 249 | 256 |
| Levered free cash flow | -100 | 447 | 173 | 363 | 407 | 419 | 140 | 189 | 396 | 334 | 145 | 269 |